Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Carcinoma, Hepatocellular
×
budigalimab
×
Clear all
Filters
3
NCT05822752
2025-08-14
LIVIGNO-1
AbbVie
Phase 2
Active not recruiting
130 enrolled